Share Investor Evening London

Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision-makers behind some of the UK’s fastest growing listed companies.
The event on Wednesday 27 November 2019 in London will include:
• An opportunity for you to talk directly with the directors and ask your questions about the companies’ core strengths and their short and long-term business strategy
• Meet fellow investors and share your investing experience
• Complimentary drinks and snacks
More about the companies presenting:
Amryt Pharma (AMYT) is a revenue-generating orphan drug company focused on acquiring, developing and commercialising products that help improve the lives of patients
Rockfire Resources (ROCK) the gold and base-metal focused explorer, announces that it has recently completed reprocessing of historical geophysical data from its 100%-owned Plateau Gold Deposit in Queensland, Australia
Silence Therapeutics (SLN) is a biotechnology company in the United Kingdom. It uses its RNA technology to develop drugs to address genetic disorders
SkinBio Therapeutics (SBTX) is a life science company. The company is engaged in the development of technology to protect, manage and restore skin utilising proteins found in human microbiota
Who Should Attend
The evening is a perfect opportunity for existing shareholders or potential investors to hear from the directors running the companies, being the individuals best placed to explain the strategy and opportunity for investors.
Evening timings
18.00 Registration and coffee
18.30 Presentations
Kieran Rooney, Vice President - Amryt Pharma (AMYT)
David Price, CEO - Rockfire Resources (ROCK)
Dr. Rob Quinn, Interim CFO - Silence Therapeutics (SLN)
Stuart Ashman, Chief Executive - SkinBioTherapeutics (SBTX)

20.00 Drinks reception and canapés
21.00 Close

For more information, visit https://www.sharesmagazine.co.uk/events/event/shares-investor-evening-london-271119